Home NDC 61703-323 Bleomycin
Product NDC 61703-323
11-digit product format 617030323
Labeler code 61703
Product ID 61703-323_6615dbd2-3bb4-40b5-8599-aa46bc0bc488
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name BLEOMYCIN
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS
Labeler Hospira, Inc.
Application ANDA065031
Marketing category ANDA
Marketing start 2000-04-10
Substance BLEOMYCIN SULFATE
Active strength 30 [USP'U]/1
Pharmacologic classes Cytoprotective Agent [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065031-001 BLEOMYCIN SULFATE BLEOMYCIN SULFATE EQ 15 UNITS BASE/VIAL INJECTABLE / INJECTION AP 2000-03-10 A065031-002 BLEOMYCIN SULFATE BLEOMYCIN SULFATE EQ 30 UNITS BASE/VIAL INJECTABLE / INJECTION AP 2000-03-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A065031-001 BLEOMYCIN SULFATE EQ 15 UNITS BASE/VIAL INJECTABLE / INJECTION AP 2000-03-10 a50c72e98297…2026-08-01 22:54:32 2026-06 A065031-002 BLEOMYCIN SULFATE EQ 30 UNITS BASE/VIAL INJECTABLE / INJECTION AP 2000-03-10 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-01 22:54:32 2026-06 A065031-001 AP 1 a50c72e98297…2026-08-01 22:54:32 2026-06 A065031-002 AP 1 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base Bleomycin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BLEOMYCIN SULFATE 30 [USP'U]/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7DP3NTV15T Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1726673 Internal RxNorm lookup 1726676 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61703-323-22 Bleomycin 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 20 61703-323-22 Bleomycin 1 in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 1 20
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded BLEOMYCIN SULFATE ACTIVE INGREDIENT 7DP3NTV15T BLEOMYCIN (BLEOMYCIN SULFATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.] 13 BLEOMYCIN ACTIVE MOIETY 40S1VHN69B BLEOMYCIN (BLEOMYCIN SULFATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.] 13 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I BLEOMYCIN (BLEOMYCIN SULFATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.] 13 SULFURIC ACID INACTIVE INGREDIENT O40UQP6WCF BLEOMYCIN (BLEOMYCIN SULFATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.] 13
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61703-323 BLEOMYCIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] 20 Current NDC, Legacy NDC, 2 package rows 20220827_905e0984-2ce3-481c-b1a0-0ef0a616479a.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 61703-323-22 61703032322 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-323-22) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE 2000-04-10 0000-00-00 No No Current